According to Accelerate Diagnostics's latest financial reports the company's current revenue (TTM) is $12.05 M. In 2022 the company made a revenue of $12.75 M an increase over the years 2021 revenue that were of $11.78 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $12.05 M | -5.43% |
2022 | $12.75 M | 8.23% |
2021 | $11.78 M | 5.53% |
2020 | $11.16 M | 20.08% |
2019 | $9.29 M | 63.97% |
2018 | $5.67 M | 35.78% |
2017 | $4.17 M | 1597.56% |
2016 | $0.24 M | 67.35% |
2015 | $0.14 M | 20.49% |
2014 | $0.12 M | 151.87% |
2013 | $0.04 M | 14.52% |
2012 | $0.04 M | -95.06% |
2011 | $0.85 M | -68.22% |
2010 | $2.69 M | 173.81% |
2009 | $0.98 M | 38.39% |
2008 | $0.71 M | 271.6% |
2007 | $0.19 M | 4.91% |
2006 | $0.18 M | -67.85% |
2005 | $0.56 M | -373.66% |
2004 | -$0.21 M | -130.4% |
2003 | $0.68 M | -9.31% |
2002 | $0.75 M | 27.23% |
2001 | $0.59 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Thermo Fisher Scientific TMO | $42.85 B | 355,294.31% | ๐บ๐ธ USA |
Becton Dickinson BDX | $19.49 B | 161,538.61% | ๐บ๐ธ USA |
PerkinElmer
PKI | $3.35 B | 27,741.87% | ๐บ๐ธ USA |
Bruker BRKR | $2.96 B | 24,483.30% | ๐บ๐ธ USA |
NanoString Technologies NSTG | $0.16 B | 1,247.32% | ๐บ๐ธ USA |
Bio-Rad Laboratories BIO | $2.67 B | 22,051.60% | ๐บ๐ธ USA |